Subscribe to Newsletter

Tomasz Sablinski

The Power List 2017 – Champions of Change

Tomasz Sablinski

Chief Executive Officer and Co-founder, Transparency Life Sciences

According to Tomasz, meaningful progress in making new therapies available to patients will be driven by the convergence of modern technology and science. “The industry must realize that the digital revolution does apply to drug development. And in practice, companies must become quicker at adopting a digital approach to clinical research, otherwise, big and small technology players will make them irrelevant.”

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine